• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/14

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

14 Cards in this Set

  • Front
  • Back
PKU
Phenylalanine hydroxylase (PAH)
Phe -> Tyr
Tyrosinemia II
Tyrosine aminotransferase (TAT)
Tyr -> p-hydroxyphenylpyruvic acid
Tyrosinemia III
HPPA dioxygenase
HPPA -> homogentisic acid
Effect of NTBC (drug)
Blocks HPPA dioxygenase, converts tyrosinemia type I to type III
Lab analyte in type III tyrosinemia
Urine: 4-OHphenyllactate
and 4-OHphenylacetate
Alkaptonuria
Homogentisate oxidase
Homogentisate -> maleylacetoacetate
Maleylacetoacetate reversibly interconverts with this normal metabolite
fumarylacetoacetate
Tyrosinemia type I
Fumarylacetoacetate hydrolase
Fumarylacetoacetate -> fumarate and acetoacetate
Excess maleylacetoacetate and fumarylacetoacetate form this
Succinylacetoacetate -> succinylacetone
Effect of succinylacetone
Inhibits PBG synthase, causing acute porphyria-like crises
Maleylacetoacetate and fumarylacetoacetate do this to liver:
Alkylating DNA damage, causing increased risk of liver cancer
Treatments for hepatorenal (type I) tyrosinemia
NTBC
(Liver transplant)
Measurement of serum tyrosine in tyrosinemia
Very variable, often normal
Lab analyte for tyrosinemia type I
succinylacetone